Global BioAccess Fund partners with companies to invest in transformative technologies addressing unmet needs in oncology, cardiovascular, CNS, and rare diseases. The fund invests in companies developing novel therapeutics and devices for serious unmet medical needs, focusing on early-stage companies needing capital for IND submission and clinical trials.

Global BioAccess Fund

At the Global BioAccess Fund we partner with forward-thinking companies to create the medicines of tomorrow. We invest in transformative technologies that address unmet needs in oncology, cardiovascular, CNS, and rare diseases. We fund early-stage companies who need capital to support IND submission and clinical trials.

Congratulations to Acesion Pharma on their publication in Nature Medicine and launching their Ph 1 trial!

We look forward to working with the Odyssey team and Board as they move multiple programs into the clinic.
https://lnkd.in/eWzTVQxh

We are thrilled to be working with Acesion Pharma, Canaan, Alpha Wave Global, LP and Novo Holdings to bring safer and more effective treatments to patients with atrial fibrillation.

https://lnkd.in/e2XDz4zX

Google

Google Cloud

Engineering

Kevin Cyr, MD

Sonia Gulati

Principal

Venture Capital Investors (Top 10K)

Late Stage Venture Investors with Investments in Hovedstaden

Investors Active in Massachusetts

Greater New York Area Venture Capital Investors

Global BioAccess Fund invests in transformative technologies that address serious unmet medical needs in oncology, rare disease, CNS, and cardiology. The company supports early-stage companies that need capital for IND submission and clinical trials. Global BioAccess Fund was founded in 2021 and is based in New York, New York.

New York

United States

North America

Vittoria Biotherapeutics Completes $25 Million in Private Financing to Propel Groundbreaking Cell Therapy Candidates

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Aug 9, 2024 4:55 PM	6f548e0a
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:06 AM	a6bbd36f
crunchbase profile	general	Nov 25, 2024 9:38 AM	313d72de
li profile	general	Aug 9, 2024 4:55 PM	1872ae59
translate crunchbase fundingrounds	general	Nov 25, 2024 2:03 PM	1eea259a
peers	general	Aug 9, 2024 4:55 PM	96e80d36
news basic	general	Aug 9, 2024 4:55 PM	ba859e2f
bundesanzeiger	filings
financials download nd	financials
private financials	financials

GLOB

COM:GLOBALBIOACCESS

Global BioAccess Fund